Some 15% of people working at the federal Center for Consumer Information and Insurance Oversight were fired last month.

Timely receipt of guideline-concordant care can improve survival and may help mitigate racial and ethnic disparities in survival among patients with inflammatory breast cancer, researchers wrote.

It is imperative to align strategies that can prevent ovarian cancer while also strengthening support for patients, caregivers, and health systems that are confronted by it,” the researchers wrote.

Republicans are aiming to cut billions in federal spending to finance tax cuts, and a lot of that money could come from Medicaid.

The New Mexico Department of Health reported the death of an unvaccinated adult who tested positive for measles.

Florida’s insurance regulator is demanding detailed prescription data on millions of patients, raising alarms over patient privacy.

The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy as first-line treatment for unresectable or metastatic, PD-L1-positive ESCC.

Though President Trump denied having any connection to Project 2025 on the campaign trail, he has pushed its health policy ...

Appendix tumors should be evaluated separately and not included in colon or colorectal cancer categories,” researchers concluded.

The volume of patient-initiated EHR messages “increased dramatically” after the onset of the COVID-19 pandemic and remained elevated through 2022, said A. Jay Holmgren, PhD.

HHS Secretary Robert F. Kennedy Jr. has rescinded the HHS policy of requiring new rules and regulations to be open to public comment before they are implemented.

Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.